These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27451928)

  • 1. Anagen effluvium secondary to
    Bains A; Verma GK; Vedant D; Negi A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):677-680. PubMed ID: 27451928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anagen effluvium.
    Kanwar AJ; Narang T
    Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced hair loss and hair growth. Incidence, management and avoidance.
    Tosi A; Misciali C; Piraccini BM; Peluso AM; Bardazzi F
    Drug Saf; 1994 Apr; 10(4):310-7. PubMed ID: 8018303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TrichoScan findings in patients with effluvium capillorum.
    Kasumagic-Halilovic E; Ovcina-Kurtovic N; Begovic B
    Skinmed; 2015; 13(2):98-101. PubMed ID: 26137734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation.
    Yun SJ; Kim SJ
    Dermatology; 2007; 215(1):36-40. PubMed ID: 17587837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced anagen effluvium: diffuse or patterned?
    Trüeb RM
    Dermatology; 2007; 215(1):1-2. PubMed ID: 17587831
    [No Abstract]   [Full Text] [Related]  

  • 7. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
    Miteva M; Misciali C; Fanti PA; Vincenzi C; Romanelli P; Tosti A
    Am J Dermatopathol; 2011 Jun; 33(4):345-50. PubMed ID: 21430504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and hair loss.
    Patel M; Harrison S; Sinclair R
    Dermatol Clin; 2013 Jan; 31(1):67-73. PubMed ID: 23159177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of colchicine intoxication caused by tubers of Gloriosa superba].
    Ide N; Suzuki A; Suzuki E; Gotou S
    Chudoku Kenkyu; 2010 Sep; 23(3):243-5. PubMed ID: 20865911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic telogen effluvium is due to a reduction in the variance of anagen duration.
    Gilmore S; Sinclair R
    Australas J Dermatol; 2010 Aug; 51(3):163-7. PubMed ID: 20695853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Bromo-2'-deoxyuridine induced effluvium via p53-mediated CD326-positive keratinocyte apoptosis in C57BL/6 mice.
    Uh KJ; Hwang WS; Bae JH; Jang DE; Yeom SC
    J Dermatol; 2017 Feb; 44(2):180-185. PubMed ID: 27543435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anagen Effluvium Following Acute Colchicine Poisoning.
    Combalia A; Baliu-Piqué C; Fortea A; Ferrando J
    Int J Trichology; 2016; 8(4):171-172. PubMed ID: 28442873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
    Sharma PK; Gautam RK; Bhardwaj M; Kar HK
    J Dermatol; 2001 Dec; 28(12):737-41. PubMed ID: 11804071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods of hair loss evaluation in patients with endocrine disorders.
    Olszewska M; Warszawik O; Rakowska A; Słowińska M; Rudnicka L
    Endokrynol Pol; 2010; 61(4):406-11. PubMed ID: 20806187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of etretinate alopecia.
    Berth-Jones J; Shuttleworth D; Hutchinson PE
    Br J Dermatol; 1990 Jun; 122(6):751-5. PubMed ID: 2369555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods of hair loss evaluation in patients with endocrine disorders].
    Olszewska M; Warszawik O; Rakowska A; Słowińska M; Rudnicka L
    Endokrynol Pol; 2011; 62 Suppl 1():29-34. PubMed ID: 22125108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.
    Kanti V; Nuwayhid R; Lindner J; Hillmann K; Stroux A; Bangemann N; Kleine-Tebbe A; Blume-Peytavi U; Garcia Bartels N
    Br J Dermatol; 2014 Mar; 170(3):643-50. PubMed ID: 24641211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine-associated anagen effluvium.
    Sonthalia S; Daulatabad D
    Indian J Dermatol Venereol Leprol; 2016; 82(3):322-4. PubMed ID: 27088942
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.